Difference between revisions of "Research/nci-role/spotlight/profiles"
Jump to navigation
Jump to search
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Profiles in Cancer Research == | + | == Profiles in Cancer Research == <!--T:1--> |
| + | <!--T:2--> | ||
The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research. | The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research. | ||
| + | <!--T:3--> | ||
{| | {| | ||
|- | |- | ||
| Line 12: | Line 14: | ||
:Sharon Savage, M.D. | :Sharon Savage, M.D. | ||
| + | <!--T:4--> | ||
:The chief of the Clinical Genetics Branch in NCI’s Division of Cancer Epidemiology and Genetics studies the association between telomere length and cancer risk. | :The chief of the Clinical Genetics Branch in NCI’s Division of Cancer Epidemiology and Genetics studies the association between telomere length and cancer risk. | ||
|} | |} | ||
| + | <!--T:5--> | ||
{| | {| | ||
|- | |- | ||
| Line 23: | Line 27: | ||
:W. Marston Linehan, M.D. | :W. Marston Linehan, M.D. | ||
| + | <!--T:6--> | ||
:The chief of the Urologic Oncology Branch in NCI’s Center for Cancer Research investigates gene pathways in kidney cancer to find new treatment strategies. | :The chief of the Urologic Oncology Branch in NCI’s Center for Cancer Research investigates gene pathways in kidney cancer to find new treatment strategies. | ||
|} | |} | ||
| + | <!--T:7--> | ||
{| | {| | ||
|- | |- | ||
| Line 34: | Line 40: | ||
:James Gulley, M.D., Ph.D. | :James Gulley, M.D., Ph.D. | ||
| + | <!--T:8--> | ||
:The head of the Clinical Trials Group in NCI’s Laboratory of Tumor Immunology and Biology explores how to harness the power of the body’s immune system to fight cancer more effectively. | :The head of the Clinical Trials Group in NCI’s Laboratory of Tumor Immunology and Biology explores how to harness the power of the body’s immune system to fight cancer more effectively. | ||
|} | |} | ||
| + | <!--T:9--> | ||
{| | {| | ||
|- | |- | ||
| Line 45: | Line 53: | ||
:Mark Schiffman, M.D., M.P.H. | :Mark Schiffman, M.D., M.P.H. | ||
| + | <!--T:10--> | ||
:The senior investigator in the Clinical Genetics Branch of NCI’s Division of Cancer Epidemiology and Genetics uses molecular epidemiology to predict and prevent cervical cancer. | :The senior investigator in the Clinical Genetics Branch of NCI’s Division of Cancer Epidemiology and Genetics uses molecular epidemiology to predict and prevent cervical cancer. | ||
|} | |} | ||
| + | <!--T:11--> | ||
{| | {| | ||
|- | |- | ||
| Line 56: | Line 66: | ||
:Christina Annunziata, M.D., Ph.D. | :Christina Annunziata, M.D., Ph.D. | ||
| + | <!--T:12--> | ||
:The investigator in NCI’s Center for Cancer Research studies the role of NF-κB signaling in ovarian cancer. | :The investigator in NCI’s Center for Cancer Research studies the role of NF-κB signaling in ovarian cancer. | ||
|} | |} | ||
| + | <!--T:13--> | ||
{| | {| | ||
|- | |- | ||
| Line 67: | Line 79: | ||
:Christal Sohl, Ph.D. | :Christal Sohl, Ph.D. | ||
| + | <!--T:14--> | ||
:The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer. | :The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer. | ||
|} | |} | ||
| + | <!--T:15--> | ||
{| | {| | ||
|- | |- | ||
| Line 78: | Line 92: | ||
:David Q. Matus, Ph.D. | :David Q. Matus, Ph.D. | ||
| + | <!--T:16--> | ||
:David Matus studies cellular invasion during normal development in the worm, C. elegans, as a model for understanding this behavior in metastatic cancer cells. | :David Matus studies cellular invasion during normal development in the worm, C. elegans, as a model for understanding this behavior in metastatic cancer cells. | ||
|} | |} | ||
</translate> | </translate> | ||
Latest revision as of 21:56, 29 October 2019
Profiles in Cancer Research
The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research.
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
